Logo image
Bis(monoacylglycerol) phosphate levels are elevated at baseline in carriers of pathogenic variants in LRRK2 and GBA1 and do not predict progression of PD in PPMI cohorts
Poster

Bis(monoacylglycerol) phosphate levels are elevated at baseline in carriers of pathogenic variants in LRRK2 and GBA1 and do not predict progression of PD in PPMI cohorts

Kalpana M. Merchant, Tanya Simuni, Janel Fedler, Chelsea Caspell-Garcia, Michael Brumm, Kelly Nudelman, Elizabeth Tengstrandt, Frank Hsieh, Roy N. Alcalay, Christopher Coffey, …
Zenodo
07/31/2022
DOI: 10.5281/zenodo.7004952
url
https://zenodo.org/record/7004952View
Open Access

Abstract

Urine Bis(monoacylglcerol) phosphate (BMP) has been identified as a biomarker that identifies carriers variants in the LRRK2 gene. The purpose of this study was to investigate BMP in patients with LRRK2-associated Parkinson's disease in a longitudinal study. We found that BMP was elevated in patients with LRRK2 PD compared to sporadic PD. We did not identify phenotypic variation associated with LRRK2.
Bis(monoacylglcerol) phosphate LRRK2 GBA1

Details

Metrics

25 Record Views
Logo image